Friday 16 April 2021 ,
Latest News
Lalmonirhat college teacher held with phensedyl | Akram hospitalised with Covid-19 symptoms | Bangladesh to demand 10pc of funds for Rohingyas in Bhasan Char: FM | Covid-19 turns India into vaccine importer from exporter | South Asia fast becoming new global epicentre of COVID-19: IFRC | COVID-19: South Korea suspends visas for Bangladeshis | BNP spreads propaganda over lockdown: Quader | Bangladesh reports highest ever 101 Covid-19 deaths in a day | Bangladesh reports highest ever 101 Covid-19 deaths in a day |
28 February, 2021 06:12:45 PM / LAST MODIFIED: 1 March, 2021 08:50:06 AM

Print

Recent study confirms Sputnik V effectiveness against COVID mutations

BSS/TASS, London
Recent study confirms Sputnik V effectiveness against COVID mutations

Russia’s Sputnik V COVID-19 vaccine has produced strong results against new mutations of coronavirus, including its UK and South African variants, Denis Logunov, a deputy director of Russia’s Gamaleya National Research Center for Epidemiology and Microbiology which developed Sputnik V, told Reuters.

“A recent study carried out by the Gamaleya Centre in Russia showed that revaccination with Sputnik V vaccine is working very well against new coronavirus mutations, including the UK and South African strains of coronavirus,” he said adding that according to the Russian researchers “believe that vector-based vaccines are actually better for future revaccinations than vaccines based on other platforms.”

Reuters reported that results of the trial were expected to be published soon.

Logunov said that the trial indicated that the revaccination did not impact the effectiveness of the vaccine.

According to the scientist, “the antibodies specific to the vectors used by the shot – which could generate an anti- vector reaction and undermine the work of the shot itself – waned ‘as early as 56 days after vaccination’,” the agency said. Russia was the first country to register its vaccine against the novel coronavirus on August 11, 2020.

The Sputnik V vaccine was developed by the Gamaleya National Research Center for Epidemiology and Microbiology of the Russian Health Ministry.

Sputnik V is a vaccine on a human adenoviral vector- based platform. The two-part vaccine is administered in two doses.

BK

 

Comments

Poll
Today's Question »
State minister for power Nasrul Hamid yesterday said everyone to have access to electricity by June. Do you think the feat achievable by the timeframe?
 Yes
 No
 No Comment
Yes 47.3%
No 48.7%
No Comment 4.1%
Video

Copyright © All right reserved.

Editor : M. Shamsur Rahman

Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Editor : M. Shamsur Rahman
Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Disclaimer & Privacy Policy
....................................................
About Us
....................................................
Contact Us
....................................................
Advertisement
....................................................
Subscription

Powered by : Frog Hosting